There are no publicly funded or private genetic testing facilities in the Northwest Territories. If you have a history of hereditary cancer in your family and feel that genetic testing is right for you, consult with your physician to discuss your options.
Learn
- Health concerns for cancer patients
- New treatments
- ALECENSARO® (alectinib) approved by Health Canada for first-line treatment of ALK-positive lung cancer
- First and Only Immuno-Oncology Treatment, Imfinzi® (durvalumab), for Stage III, Unresectable Non-Small Cell Lung Cancer Now Approved in Canada
- Health Canada approves Ipsen’s Somatuline® Autogel® for the treatment of carcinoid syndrome in adult patients with neuroendocrine tumours (NETs)
- Health Canada approves KISQALI™ for the treatment of HR-positive and HER2-negative metastatic breast cancer in postmenopausal women in combination with letrozole as an initial endocrine-based therapy
- Health Canada approves TECENTRIQ® (atezolizumab) for the treatment of patients with metastatic non-small cell lung cancer
- Lynparza® (olaparib) Receives New Indication for BRCA-Mutated Metastatic Breast Cancer
- Lynparza® (olaparib) tablets receive approval as maintenance therapy treatment for ovarian cancer regardless of BRCA status
- Health Canada Approves RITUXAN® Subcutaneous Formulation for Canadians with Chronic Lymphocytic Leukemia
- Health Canada Approves New Indication for ZYTIGA®* (abiraterone acetate), Broadening its Use for Treatment of Newly Diagnosed Metastatic Prostate Cancer
- Taiho Pharma Canada, Inc. announces Health Canada approval of LONSURF® (trifluridine and tipiracil tablets) for metastatic colorectal cancer
- Tagrisso® (osimertinib) receives full Health Canada approval for targeted treatment of non-small cell lung cancer
- Quebec and New Brunswick Become First Provinces to Provide Public Funding of IBRANCE™ for the First-Line Treatment of Metastatic Breast Cancer
- Research resources
- Asbestos, mesothelioma & lung cancer
- Blood clots and cancer
- Bone health in Cancer
- Caregivers
- Chemo-induced nausea and vomiting (CINV)
- Chemo-induced nausea and vomiting (CINV) overview
- Chemo-induced nausea and vomiting (CINV) resources
- Chemo-induced nausea and vomiting (CINV) videos
- A patient charter for CINV management (UK)
- What is chemo-induced nausea and vomiting?
- What you need to know about preventing chemo-induced nausea and vomiting (CINV)
- Clinical Trials
- Genetic testing
- Febrile Neutropenia
- HPV and cancer
- Canadian organizations mark the first annual international HPV awareness day: Give love, not HPV
- HPV vaccine expanded to include ‘at-risk’ boys
- Key points for policy-makers and health professionals
- WHO Information on Human papillomavirus (HPV) and cervical cancer
- Human Papillomavirus and Related Cancers in Canada, Fact Sheet 2010
- Reframing the debate
- WHO/ICO Information Centre on Human Papilloma Virus (HPV) and Cervical Cancer
- Lymphedema
- Medical Cannabis
- Information on Medical Cannabis
- Part One: Why Cannabis Works
- Part Two: Medical Conditions & Products
- Part Three: Accessing Medical Cannabis
- Part Four: Medical Cannabis Myths & Facts
- PDQ Cancer Information Summaries
- Medical Cannabis Infographics
- Medicinal cannabis: Used throughout the ages for medicinal, therapeutic and religious purposes
- Cannabinoids: The chemical components of cannabis
- Potential therapeutic uses of medical cannabis
- Medical cannabis strains
- Cannabis contamination
- Want to learn more about the science of medical cannabis?
- Webinars & Slideshows
- Glossary of terms
- Medical Cannabis “How To”
- Medical Cannabis in the Media
- Patient Stories
- Health Canada Reports Increasing Use Of Cannabis And Cannabis Vaporization
- Canadian Cancer Survivor Network Submission : Task Force on Marijuana Legalization and Regulation
- A Framework for the Legalization and Regulation of Cannabis in Canada
- Information on Medical Cannabis
- New treatments